BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36318377)

  • 1. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer.
    Rather TB; Parveiz I; Bhat GA; Rashid G; Wani RA; Khan IY; Mudassar S
    Clin Exp Med; 2023 Oct; 23(6):2385-2405. PubMed ID: 36318377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
    J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1.
    Xu K; Liu X; Mao X; Xue L; Wang R; Chen L; Chu X
    Cell Physiol Biochem; 2015; 35(2):499-515. PubMed ID: 25613903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
    Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
    Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.
    Shi S; Wang Q; Du X
    J Appl Genet; 2023 Dec; 64(4):779-796. PubMed ID: 37782449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
    Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
    Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.
    Li X; Ma K; Song S; Shen F; Kuang T; Zhu Y; Liu Z
    Clin Exp Med; 2018 Aug; 18(3):413-420. PubMed ID: 29804142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
    Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
    Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
    J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
    Kuai XY; Lei ZY; Liu XS; Shao XY
    Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
    Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
    Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
    Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
    Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.